ARQT

26.3602.98%
KR

Keith R. Leonard

Independent Chairman of the Board

Mr. Keith R. Leonard, Jr., M.S., M.B.A., is Chairman of Antag Therapeutics ApS from 2026. He has been Independent Director of Arcutis Biotherapeutics, Inc. since September 02, 2021 and also serves as its Independent Chairman of the Board Since November 4, 2024. He served as a Venture Partner at Arch Venture Partners, L.P. He served as Chairman of Unity Biotechnology, Inc. until June 27, 2025 and served as its Director since 2016 until June 27, 2025. Mr. Leonard served as the Executive Chairman of Unity Biotechnology, Inc. since October 2016 and served as its Chief Executive Officer since October 2016 until March 20, 2020. He served as Chairman of Unity Biotechnology, Inc. since January 2016. Mr. Leonard has an experience in the pharmaceutical industry. He serves as the President and Chief Executive Officer at AESTHERx Inc. He serves at UCLA Venture Capital Fund. He served as the Chief Executive Officer and President of Kythera Biopharmaceuticals, Inc from August 2005 until October 2015. He co-founded Kythera Biopharmaceuticals, Inc in 2005. He served as a Senior Vice president and General Manager at Amgen Europe and was responsible for all commercial operations in 28 countries. From May 1995 to August 1995, Mr. Leonard was responsible to help set up the company's manufacturing operations. His career at Amgen Europe included establishing Amgen's presence in rheumatology with the creation of the Rheumatology Business Unit, Head of Information Management and leadership roles in Sales and Marketing, Engineering, Operations and Finance. Mr. Leonard is a Veteran of Amgen Inc. having worked from October 1991 to November 2004, leading various functions including engineering, IT and ultimately as General Manager of Amgen Europe. He expanded its operations into 11 additional countries and oversaw numerous successful product launches. As a Vice President for its rheumatology business unit, he prepared the launch of arthritis drug Kineret. He served as the Chairman at Sienna Biopharmaceuticals, Inc. since 2016 and was Director from February 2016 to December 2019. He has been a Director at Intuitive Surgical, Inc. since January 28, 2016 and Sanifit Laboratories S.L. since May 2016. Mr. Leonard served as a Director of Affymax, Inc. from December 2007 to June 4, 2013. He served as an Independent Director of Anacor Pharmaceuticals, Inc. from May 30, 2014 to June 24, 2016. Mr. Leonard served as a Director of Kythera Biopharmaceuticals, Inc from August 2005 to October 1, 2015. He served as an Independent Director of ARYx Therapeutics, Inc. from September 2005 to February 1, 2011. He was formerly an active-duty officer in the United States Navy. Mr. Leonard received a Master of Business Administration from The Anderson School of Management, University of California, Los Angeles between 1993 to 1995, a Master of Science in Mechanical Engineering from University of California, Berkeley between 1988 to 1990, a Bachelor of Arts in History from University of Maryland, College Park between 1985 to 1987 and a Bachelor of Science in Engineering from University of California, Los Angeles between 1979 to 1984.

Positions